Creating a portfolio of first-in-class small molecules in neuro-regeneration
$320—480m (Dealroom.co estimates Feb 2021.)
San Diego California (HQ)
Recent News about Pipeline TherapeuticsEdit
Tech stackLearn more about the technologies and tools that this company uses.